- Stocks making the biggest moves in the premarket: Gilead Sciences, Starbucks, BP, Coty & moreCNBC
- Covid-19 Drug Remdesivir to Cost $3,120 for Typical Patient on Private InsuranceThe Wall Street Journal
- Gilead sets US price for Covid-19 drug remdesivir at $3120 for typical treatmentCNBC Television
- Gilead’s coronavirus treatment remdesivir to cost $3,120 per U.S. patient with private insuranceCNBC
- Gilead prices coronavirus drug at $2,340 for rich countriesThe Boston Globe
- View Full Coverage on Google News